DE VITA, GABRIELLA
DE VITA, GABRIELLA
DIPARTIMENTO DI MEDICINA MOLECOLARE E BIOTECNOLOGIE MEDICHE
Expression of the RET oncogene induces differentiation of SK-N-BE neuroblastoma cells.
1995 D'Alessio, A; DE VITA, Gabriella; Cal, G; Nitsch, Lucio; Fusco, Alfredo; Vecchio, G; Santelli, G; Santoro, M; DE FRANCISCIS, V.
Tyrosine 1062 of RET-MEN2A mediates activation of Akt (protein kinase B) and mitogen-activated protein kinase pathways leading to PC12 cell survival
2000 De Vita, Gabriella; Melillo, Rosa Marina; Carlomagno, Francesca; Visconti, R; Castellone, Md; Bellacosa, A; Billaud, M; Fusco, Alfredo; Tsichlis, Pn; Santoro, M.
Glial cell line-derived neurotrophic factor differentially stimulates ret mutants associated with the multiple endocrine neoplasia type 2 syndromes and Hirschsprung's disease
1998 Carlomagno, F.; Melillo, Rosa Marina; Visconti, R.; Salvatore, G.; De Vita, Gabriella; Lupoli, G.; Yu, Y. B.; Jing, S. Q.; Vecchio, Giancarlo; Fusco, Alfredo; Santoro, M.
A genetic screen implicates miRNA-372 and miRNA-373 as oncogenes in testicular germ cell tumors
2006 Voorhoeve, Pm; LE SAGE, C; Schrier, M; Gillis, Aj; Stoop, H; Nagel, R; Liu, Yp; VAN DUIJSE, J; Drost, J; Griekspoor, A; Zlotorynski, E; Yabuta, N; DE VITA, Gabriella; Nojima, H; Looijenga, Lh; Agami, R.
Akt/protein kinase B promotes survival and hormone-independent proliferation of thyroid cells in the absence of dedifferentiating and transforming effects
2000 DE VITA, Gabriella; Berlingieri, Mt; Visconti, R; Castellone, Md; Viglietto, G; Baldassarre, G; Zannini, M; Bellacosa, A; Tsichlis, Pn; Fusco, Alfredo; Santoro, Massimo
RET/papillary thyroid carcinoma oncogenic signaling through the Rap1 small GTPase
2007 DE FALCO, V; Castellone, Md; DE VITA, Gabriella; Cirafici, Am; Hershman, Jm; Guerrero, C; Fusco, Alfredo; Melillo, ROSA MARINA; Santoro, Massimo
Molecular heterogeneity of RET loss of function in Hirschsprung's disease
1996 Carlomagno, F.; DE VITA, Gabriella; Berlingieri, M. T.; Defranciscis, V.; Melillo, ROSA MARINA; Colantuoni, V.; Kraus, M. H.; Difiore, P. P.; Fusco, Alfredo; Santoro, M.
A mammalian microRNA expression atlas based on small RNA library sequencing.
2007 Landgraf, P; Rusu, M; Sheridan, R; Sewer, A; Iovino, N; Aravin, A; Pfeffer, S; Rice, A; Kamphorst, Ao; Landthaler, M; Lin, C; Socci, Nd; Hermida, L; Fulci, V; Chiaretti, S; Foa, R; Schliwka, J; Fuchs, U; Novosel, A; Muller, Ru; Schermer, B; Bissels, U; Inman, J; Phan, Q; Chien, M; Weir, Db; Choksi, R; DE VITA, Gabriella; Frezzetti, D; Trompeter, Hi; Hornung, V; Teng, G; Hartmann, G; Palkovits, M; DI LAURO, Roberto; Wernet, P; Macino, G; Rogler, Ce; Nagle, Jw; J, Ju; Papavasiliou, Fn; Benzing, T; Lichter, P; Tam, W; Brownstein, Mj; Bosio, A; Borkhardt, A; Russo, Jj; Sander, C; Zavolan, M; Tuschl, T.
A potential pathogenetic mechanism for multiple endocrine neoplasia type 2 syndromes involves ret-induced impairment of terminal differentiation of neuroepithelial cells.
1996 D., Califano; A., D'Alessio; G. L., Colucci D'Amato; DE VITA, Gabriella; C., Monaco; G., Santelli; P. P., Di Fiore; Vecchio, Giancarlo; Fusco, Alfredo; Santoro, Massimo; V. d., Franciscis
MicroRNAs
2007 DE VITA, Gabriella
miR-21 deregulation in thyroid cancer
2008 Frezzetti, Daniela; Guerra, C; Barbacid, M; DI LAURO, Roberto; DE VITA, Gabriella
Role of wnt4 in thyroid cancer
2009 DE MENNA, Marta; Mancini, D; Ferraro, A; DI LAURO, Roberto; DE VITA, Gabriella
Association between the expression of E1 A oncogene and increased sensitivity to growth inhibition induced by sustained levels of cAMP in rat thyroid cells
2000 Villone, G.; DE VITA, Gabriella; Chieffi, P.; Picascia, A.; Stanzione, R.; Santoro, M.; Fusco, Alfredo; Tramontano, Donatella
Ras-mediated apoptosis of PC CL 3 rat thyroid cells induced by RET/PTC oncogenes
2003 M. D., Castellone; A. M., Cirafici; DE VITA, Gabriella; V. D., Falco; L., Malorni; G., Tallini; J. A., Fagin; Fusco, Alfredo; Melillo, ROSA MARINA; M., Santoro
The different RET-activating capability of mutations of cysteine 620 or cysteine 634 correlates with the multiple endocrine neoplasia type 2 disease phenotype.
1997 Carlomagno, Francesca; G., Salvatore; A. M., Cirafici; DE VITA, Gabriella; Melillo, ROSA MARINA; V. d., Franciscis; M., Billaud; Fusco, Alfredo; Santoro, Massimo
p53 genes mutated in the DNA binding site or at a specific COOH-terminal site exert divergent effects on thyroid cell growth and differentiation.
1998 Casamassimi, A; Miano, Mg; Porcellini, Antonio; DE VITA, Gabriella; de Nigris, F; Zannini, M; DI LAURO, Roberto; Russo, Tommaso; Avvedimento, VITTORIO ENRICO; Fusco, Alfredo
Two distinct mutations of the RET receptor causing Hirschsprung's disease impair the binding of signalling effectors to a multifunctional docking site.
1999 O., Geneste; C., Bidaud; DE VITA, Gabriella; R. M., Hofstra; S., Tartare Deckert; C. H., Buys; G. M., Lenoir; Santoro, Massimo; M., Billaud
Expression of the RET/PTC1 oncogene impairs the activity of TTF-1 and Pax-8 thyroid transcription factors.
1998 DE VITA, Gabriella; M., Zannini; A. M., Cirafici; Melillo, ROSA MARINA; DI LAURO, Roberto; Fusco, Alfredo; Santoro, Massimo
Upregulation of miR-21 by Ras in vivo and its role in tumor growth
2011 Frezzetti, D.; DE MENNA, Marta; Zoppoli, P.; Guerra, C.; Ferraro, A.; Bello, A. M.; De Luca, P.; Calabrese, C.; Fusco, Alfredo; Ceccarelli, M.; Zollo, Massimo; Barbacid, M.; DI LAURO, Roberto; DE VITA, Gabriella
A potential pathogenetic mechanism for multiple endocrine neoplasia type 2 syndromes involves ret-induced impairment of terminal differentiation of neuroepithelial cells
1996 D., Califano; D'Alessio, A.; COLUCCI DAMATO, L.; DE VITA, Gabriella; Monaco, C.; Santelli, G.; DI FIORE, P. P.; Vecchio, Giancarlo; Fusco, Alfredo; Santoro, M.; DE FRANCISCIS, V.
| Titolo | Tipologia | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|---|
| Expression of the RET oncogene induces differentiation of SK-N-BE neuroblastoma cells. | 1.1 Articolo in rivista | 1995 | D'Alessio, A; DE VITA, Gabriella; Cal, G; Nitsch, Lucio; Fusco, Alfredo; Vecchio, G; Santelli, G; Santoro, M; DE FRANCISCIS, V. | |
| Tyrosine 1062 of RET-MEN2A mediates activation of Akt (protein kinase B) and mitogen-activated protein kinase pathways leading to PC12 cell survival | 1.1 Articolo in rivista | 2000 | De Vita, Gabriella; Melillo, Rosa Marina; Carlomagno, Francesca; Visconti, R; Castellone, Md; Bellacosa, A; Billaud, M; Fusco, Alfredo; Tsichlis, Pn; Santoro, M. | |
| Glial cell line-derived neurotrophic factor differentially stimulates ret mutants associated with the multiple endocrine neoplasia type 2 syndromes and Hirschsprung's disease | 1.1 Articolo in rivista | 1998 | Carlomagno, F.; Melillo, Rosa Marina; Visconti, R.; Salvatore, G.; De Vita, Gabriella; Lupoli, G.; Yu, Y. B.; Jing, S. Q.; Vecchio, Giancarlo; Fusco, Alfredo; Santoro, M. | |
| A genetic screen implicates miRNA-372 and miRNA-373 as oncogenes in testicular germ cell tumors | 1.1 Articolo in rivista | 2006 | Voorhoeve, Pm; LE SAGE, C; Schrier, M; Gillis, Aj; Stoop, H; Nagel, R; Liu, Yp; VAN DUIJSE, J; Drost, J; Griekspoor, A; Zlotorynski, E; Yabuta, N; DE VITA, Gabriella; Nojima, H; Looijenga, Lh; Agami, R. | |
| Akt/protein kinase B promotes survival and hormone-independent proliferation of thyroid cells in the absence of dedifferentiating and transforming effects | 1.1 Articolo in rivista | 2000 | DE VITA, Gabriella; Berlingieri, Mt; Visconti, R; Castellone, Md; Viglietto, G; Baldassarre, G; Zannini, M; Bellacosa, A; Tsichlis, Pn; Fusco, Alfredo; Santoro, Massimo | |
| RET/papillary thyroid carcinoma oncogenic signaling through the Rap1 small GTPase | 1.1 Articolo in rivista | 2007 | DE FALCO, V; Castellone, Md; DE VITA, Gabriella; Cirafici, Am; Hershman, Jm; Guerrero, C; Fusco, Alfredo; Melillo, ROSA MARINA; Santoro, Massimo | |
| Molecular heterogeneity of RET loss of function in Hirschsprung's disease | 1.1 Articolo in rivista | 1996 | Carlomagno, F.; DE VITA, Gabriella; Berlingieri, M. T.; Defranciscis, V.; Melillo, ROSA MARINA; Colantuoni, V.; Kraus, M. H.; Difiore, P. P.; Fusco, Alfredo; Santoro, M. | |
| A mammalian microRNA expression atlas based on small RNA library sequencing. | 1.1 Articolo in rivista | 2007 | Landgraf, P; Rusu, M; Sheridan, R; Sewer, A; Iovino, N; Aravin, A; Pfeffer, S; Rice, A; Kamphorst, Ao; Landthaler, M; Lin, C; Socci, Nd; Hermida, L; Fulci, V; Chiaretti, S; Foa, R; Schliwka, J; Fuchs, U; Novosel, A; Muller, Ru; Schermer, B; Bissels, U; Inman, J; Phan, Q; Chien, M; Weir, Db; Choksi, R; DE VITA, Gabriella; Frezzetti, D; Trompeter, Hi; Hornung, V; Teng, G; Hartmann, G; Palkovits, M; DI LAURO, Roberto; Wernet, P; Macino, G; Rogler, Ce; Nagle, Jw; J, Ju; Papavasiliou, Fn; Benzing, T; Lichter, P; Tam, W; Brownstein, Mj; Bosio, A; Borkhardt, A; Russo, Jj; Sander, C; Zavolan, M; Tuschl, T. | |
| A potential pathogenetic mechanism for multiple endocrine neoplasia type 2 syndromes involves ret-induced impairment of terminal differentiation of neuroepithelial cells. | 1.1 Articolo in rivista | 1996 | D., Califano; A., D'Alessio; G. L., Colucci D'Amato; DE VITA, Gabriella; C., Monaco; G., Santelli; P. P., Di Fiore; Vecchio, Giancarlo; Fusco, Alfredo; Santoro, Massimo; V. d., Franciscis | |
| MicroRNAs | 8.02 Comunicazioni a Convegni o Seminari | 2007 | DE VITA, Gabriella | |
| miR-21 deregulation in thyroid cancer | 1.5 Abstract in rivista | 2008 | Frezzetti, Daniela; Guerra, C; Barbacid, M; DI LAURO, Roberto; DE VITA, Gabriella | |
| Role of wnt4 in thyroid cancer | 1.5 Abstract in rivista | 2009 | DE MENNA, Marta; Mancini, D; Ferraro, A; DI LAURO, Roberto; DE VITA, Gabriella | |
| Association between the expression of E1 A oncogene and increased sensitivity to growth inhibition induced by sustained levels of cAMP in rat thyroid cells | 1.1 Articolo in rivista | 2000 | Villone, G.; DE VITA, Gabriella; Chieffi, P.; Picascia, A.; Stanzione, R.; Santoro, M.; Fusco, Alfredo; Tramontano, Donatella | |
| Ras-mediated apoptosis of PC CL 3 rat thyroid cells induced by RET/PTC oncogenes | 1.1 Articolo in rivista | 2003 | M. D., Castellone; A. M., Cirafici; DE VITA, Gabriella; V. D., Falco; L., Malorni; G., Tallini; J. A., Fagin; Fusco, Alfredo; Melillo, ROSA MARINA; M., Santoro | |
| The different RET-activating capability of mutations of cysteine 620 or cysteine 634 correlates with the multiple endocrine neoplasia type 2 disease phenotype. | 1.1 Articolo in rivista | 1997 | Carlomagno, Francesca; G., Salvatore; A. M., Cirafici; DE VITA, Gabriella; Melillo, ROSA MARINA; V. d., Franciscis; M., Billaud; Fusco, Alfredo; Santoro, Massimo | |
| p53 genes mutated in the DNA binding site or at a specific COOH-terminal site exert divergent effects on thyroid cell growth and differentiation. | 1.1 Articolo in rivista | 1998 | Casamassimi, A; Miano, Mg; Porcellini, Antonio; DE VITA, Gabriella; de Nigris, F; Zannini, M; DI LAURO, Roberto; Russo, Tommaso; Avvedimento, VITTORIO ENRICO; Fusco, Alfredo | |
| Two distinct mutations of the RET receptor causing Hirschsprung's disease impair the binding of signalling effectors to a multifunctional docking site. | 1.1 Articolo in rivista | 1999 | O., Geneste; C., Bidaud; DE VITA, Gabriella; R. M., Hofstra; S., Tartare Deckert; C. H., Buys; G. M., Lenoir; Santoro, Massimo; M., Billaud | |
| Expression of the RET/PTC1 oncogene impairs the activity of TTF-1 and Pax-8 thyroid transcription factors. | 1.1 Articolo in rivista | 1998 | DE VITA, Gabriella; M., Zannini; A. M., Cirafici; Melillo, ROSA MARINA; DI LAURO, Roberto; Fusco, Alfredo; Santoro, Massimo | |
| Upregulation of miR-21 by Ras in vivo and its role in tumor growth | 1.1 Articolo in rivista | 2011 | Frezzetti, D.; DE MENNA, Marta; Zoppoli, P.; Guerra, C.; Ferraro, A.; Bello, A. M.; De Luca, P.; Calabrese, C.; Fusco, Alfredo; Ceccarelli, M.; Zollo, Massimo; Barbacid, M.; DI LAURO, Roberto; DE VITA, Gabriella | |
| A potential pathogenetic mechanism for multiple endocrine neoplasia type 2 syndromes involves ret-induced impairment of terminal differentiation of neuroepithelial cells | 1.1 Articolo in rivista | 1996 | D., Califano; D'Alessio, A.; COLUCCI DAMATO, L.; DE VITA, Gabriella; Monaco, C.; Santelli, G.; DI FIORE, P. P.; Vecchio, Giancarlo; Fusco, Alfredo; Santoro, M.; DE FRANCISCIS, V. |